Dantrolene Therapy

Dantrolene Therapy is a pharmacological intervention classified under skeletal muscle relaxants, distinguished by its mechanism of action involving direct inhibition of calcium release from the sarcoplasmic reticulum in response to ryanodine receptor activation, thereby reducing spasticity without suppressing spinal reflexes.

411

Publications

16.6K

Citations

1.5K

Authors

535

Institutions

Publications per year

2017–2026

45

Variants

Dantrolene Treatment

Authors

1.5K

  1. PD
    Paul D. Allen

    Brigham and Women's Hospital, United States

    8 publications · 430 citations

    8

    h-index

  2. GA
    Gerald A. Gronert

    Mayo Clinic, United States

    8 publications · 689 citations

    8

    h-index

  3. JR
    José R. López

    Brigham and Women's Hospital, United States

    8 publications · 357 citations

    8

    h-index

  4. ME
    Mehmet Emin Büyükokuroğlu

    Atatürk University, Türkiye

    8 publications · 527 citations

    8

    h-index

  5. JP
    Jerome Parness

    Johnson University, United States

    7 publications · 458 citations

    7

    h-index

1–5 of 1.5K

Venues

  1. Anesthesiology

    33 publications · 1.6K citations

    23

    h-index

  2. PubMed

    Repository · 38 publications · 1.1K citations

    21

    h-index

  3. Anesthesia & Analgesia

    19 publications · 1.1K citations

    17

    h-index

  4. European Journal of Pharmacology

    EJP · 14 publications · 301 citations

    13

    h-index

  5. Anaesthesia

    9 publications · 270 citations

    9

    h-index

1–5